达晖生物 (873195.OC)

+ 收藏

资产负债表(达晖生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报
上市前/上市后 上市后上市后上市后
报表类型 合并报表合并报表合并报表
流动资产:
 货币资金(元) 5,101,973.8012,741,785.2512,395,487.60
  其中:交易性金融资产(元) 6,750,964.785,111,568.072,700,000.00
 应收票据及应收账款(元) 11,684,771.1811,713,268.7514,192,828.70
  其中:应收账款(元) 11,684,771.1811,713,268.7514,192,828.70
 预付款项(元) 939,767.801,720,557.852,227,110.19
 其他应收款(元) 336,867.29324,706.09338,185.62
 存货(元) 5,979,058.844,520,394.554,931,860.51
 其他流动资产(元) 492,075.71563,774.74738,237.39
 流动资产合计(元) 31,285,479.4036,696,055.3037,523,710.01
非流动资产:
 固定资产(元) 2,651,968.112,806,651.572,939,352.62
 使用权资产(元) 1,047,917.651,502,794.17946,161.64
 长期待摊费用(元) 201,486.54249,821.64298,156.74
 递延所得税资产(元) 1,360,442.541,549,227.211,036,065.26
 非流动资产合计(元) 5,261,814.846,108,494.595,219,736.26
资产总计(元) 36,547,294.2442,804,549.8942,743,446.27
流动负债:
 短期借款(元) 200,241.673,746,613.863,745,895.82
 应付票据及应付账款(元) 1,212,061.982,286,180.232,554,663.04
  其中:应付账款(元) 1,212,061.982,286,180.232,554,663.04
 合同负债(元) 126,296.55111,896.33123,706.19
 应付职工薪酬(元) 1,270,959.981,536,981.42629,690.60
 应交税费(元) 40,519.7930,515.2823,888.81
 应付股利(元) --1,800,000.00
 其他应付款(元) 180,371.42263,132.14642,931.85
 一年内到期的非流动负债(元) 4,043,465.713,894,619.556,473,710.74
 其他流动负债(元) 16,418.5511,563.9719,014.98
 流动负债合计(元) 7,090,335.6511,881,502.7816,013,502.03
非流动负债:
 长期借款(元) 5,918,946.946,875,601.253,718,983.19
 租赁负债(元) 356,156.01698,348.42376,868.05
 递延所得税负债(元) 184,729.92262,421.11-
 非流动负债合计(元) 6,459,832.877,836,370.784,095,851.24
负债合计(元) 13,550,168.5219,717,873.5620,109,353.27
所有者权益(或股东权益):
 实收资本或股本(元) 18,000,000.0018,000,000.0018,000,000.00
 资本公积(元) 8,512.958,512.958,512.95
 盈余公积(元) 1,365,788.281,213,473.251,126,238.17
 未分配利润(元) 3,622,824.493,864,690.133,499,341.88
 归属于母公司股东权益合计(元) 22,997,125.7223,086,676.3322,634,093.00
 股东权益合计(元) 22,997,125.7223,086,676.3322,634,093.00
负债和股东权益合计(元) 36,547,294.2442,804,549.8942,743,446.27
公告日期 2024-08-262024-04-292023-08-28
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院